DaVita (NYSE: DVA) CCO sells 15,000 shares and exercises 5,784 SARs

Filing Impact

(Very High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

DaVita Inc.’s Chief Compliance Officer James O. Hearty reported an option-style exercise and subsequent stock sale. On May 14, 2026, he exercised 5,784 Stock Appreciation Rights at $110.63 per share, receiving common stock. Of these shares, 3,231 were withheld to pay the base price and 1,117 were withheld to cover tax obligations.

On May 15, 2026, he completed an open-market sale of 15,000 DaVita common shares at a weighted average price of $193.983, within a price range of $193.360–$199.840. Following these transactions, he directly owns 22,389 DaVita common shares.

Insights

DaVita’s CCO exercised SARs and sold 15,000 shares, retaining 22,389.

The filing shows James O. Hearty exercising 5,784 Stock Appreciation Rights at a base price of $110.63 on May 14, 2026. Most resulting shares were either applied to the base-price obligation or withheld for taxes, a standard outcome for these instruments.

The next day he executed an open-market sale of 15,000 common shares at a weighted average of $193.983, with trades ranging from $193.360 to $199.840. After all transactions, Hearty directly holds 22,389 shares, indicating a reduced but continuing equity stake.

The derivativeSummary is empty, meaning no Stock Appreciation Rights from this grant remain outstanding after the exercise. Overall, this combination of exercise, withholdings, and partial share sale appears as a routine liquidity and tax-management sequence rather than a transformative event.

Insider Trade Summary

Net Seller: 15,000 shares ($2,909,745)

Net Sell 5 txns

Insider HEARTY JAMES O

Role Chief Compliance Officer

Sold 15,000 shs ($2.91M)

Type	Security	Shares	Price	Value
Sale	Common Stock	15,000	$193.983	$2.91M
Exercise	Stock Appreciation Rights	5,784	$0.00	--
Exercise	Common Stock	5,784	$110.63	$640K
Disposition	Common Stock	3,231	$198.10	$640K
Tax Withholding	Common Stock	1,117	$198.10	$221K

Holdings After Transaction: Common Stock — 22,389 shares (Direct, null); Stock Appreciation Rights — 0 shares (Direct, null)

Footnotes (1)

Represents the shares withheld in payment of the base price in connection with the exercise of Stock Appreciation Rights reported on this Form 4. Represents the shares withheld to satisfy the tax withholding obligation in connection with the exercise of Stock Appreciation Rights reported on this Form 4. Represents the weighted average sale price of $193.983. The range of prices for the sale of these shares was $193.360 - $199.840 rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. The Stock Appreciation Rights were granted on March 15, 2022, which vested 50% each on March 15, 2025 and March 15, 2026.

Key Figures

Open-market sale: 15,000 shares at $193.983 Shares held after sale: 22,389 shares SARs exercised: 5,784 shares at $110.63 +4 more

7 metrics

Open-market sale 15,000 shares at $193.983 Common Stock sale on May 15, 2026; weighted average price

Shares held after sale 22,389 shares Direct DaVita common stock ownership after May 15, 2026 transaction

SARs exercised 5,784 shares at $110.63 Stock Appreciation Rights exercise on May 14, 2026; base price

Shares withheld for base price 3,231 shares Withheld in payment of base price on SAR exercise

Shares withheld for taxes 1,117 shares Withheld to satisfy tax withholding obligation on SAR exercise

Sale price range $193.360–$199.840 Range of individual trade prices for 15,000-share sale

SAR grant and expiry Granted 3/15/2022, expires 3/15/2027 Stock Appreciation Rights terms as disclosed in footnote

Key Terms

Stock Appreciation Rights, weighted average sale price, tax withholding obligation, Disposition to issuer, +1 more

5 terms

Stock Appreciation Rights financial

"The Stock Appreciation Rights were granted on March 15, 2022, which vested 50% each on March 15, 2025 and March 15, 2026."

Stock appreciation rights (SARs) are a form of employee compensation that give the holder the right to receive the increase in a company's stock price over a set baseline, paid in cash or shares, without having to buy the stock. For investors, SARs matter because they can create future cash outflows or share dilution and signal how a company rewards and motivates executives — similar to giving a bonus tied directly to how well the company’s stock performs.

weighted average sale price financial

"Represents the weighted average sale price of $193.983."

tax withholding obligation financial

"Represents the shares withheld to satisfy the tax withholding obligation in connection with the exercise of Stock Appreciation Rights reported on this Form 4."

Disposition to issuer financial

"transaction_code_description: "Disposition to issuer""

derivative exercise/conversion financial

"transaction_action: "derivative exercise/conversion""

Form 4 Insider Transactions: What Each Field Means →

05/18/2026 - 04:08 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HEARTY JAMES O

(Last)

(First)

(Middle)

C/O DAVITA INC.

2000 16TH STREET

(Street)

DENVER

COLORADO

80202

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
DAVITA INC. [ DVA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Compliance Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/14/2026		M		5,784	A	$110.63	41,737	D
Common Stock	05/14/2026		D		3,231⁽¹⁾	D	$198.1	38,506	D
Common Stock	05/14/2026		F		1,117⁽²⁾	D	$198.1	37,389	D
Common Stock	05/15/2026		S		15,000	D	$193.983⁽³⁾	22,389	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Appreciation Rights	$110.63	05/14/2026		M			5,784	⁽⁴⁾	03/15/2027	Common Stock	5,784	$0	0	D

Explanation of Responses:

1. Represents the shares withheld in payment of the base price in connection with the exercise of Stock Appreciation Rights reported on this Form 4.

2. Represents the shares withheld to satisfy the tax withholding obligation in connection with the exercise of Stock Appreciation Rights reported on this Form 4.

3. Represents the weighted average sale price of $193.983. The range of prices for the sale of these shares was $193.360 - $199.840 rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

4. The Stock Appreciation Rights were granted on March 15, 2022, which vested 50% each on March 15, 2025 and March 15, 2026.

Remarks:

	/s/ Stephanie Berberich, Attorney-in-Fact	05/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did DaVita (DVA) report for James O. Hearty?

DaVita reported that Chief Compliance Officer James O. Hearty exercised 5,784 Stock Appreciation Rights and sold 15,000 common shares. The exercise occurred on May 14, 2026, followed by an open-market sale on May 15, 2026, as detailed in the Form 4.

How many DaVita (DVA) shares did the CCO sell and at what price?

He sold 15,000 DaVita common shares in an open-market transaction at a weighted average price of $193.983 per share. The sale price ranged from $193.360 to $199.840, according to the weighted-average price disclosure in the Form 4 footnote.

How many DaVita (DVA) shares does the CCO hold after these transactions?

After completing the exercise and sale transactions, James O. Hearty directly holds 22,389 DaVita common shares. This post-transaction balance is reported explicitly as the total shares following the May 15, 2026 open-market sale entry in the Form 4.

What Stock Appreciation Rights did the DaVita (DVA) CCO exercise?

Hearty exercised 5,784 Stock Appreciation Rights granted on March 15, 2022, with a base price of $110.63 per share. A footnote explains these rights vested 50% on March 15, 2025 and 50% on March 15, 2026, and were fully exercised in this Form 4.

How were taxes and base price obligations handled in the DaVita (DVA) insider exercise?

In connection with the Stock Appreciation Rights exercise, 3,231 shares were withheld to pay the base price and 1,117 shares were withheld to satisfy tax obligations. Footnotes specify these withholdings, clarifying they were not open-market sales but settlement mechanisms.

Does the DaVita (DVA) CCO still have Stock Appreciation Rights outstanding?

The Form 4 derivative section shows 5,784 Stock Appreciation Rights exercised into common shares, with zero remaining derivative shares afterward. The derivativeSummary is empty, indicating no Stock Appreciation Rights from this reported grant remain outstanding following the exercise.